Is ACE-031 FDA approved?
No. This profile records ACE-031 as not FDA approved and for research use only.
MORE CONTEXT ›
Review the regulatory and source details on this page for the current context.
Metabolic CATEGORY
ACE-031
THE MUSCLE UNLEASHED
ActRIIB-Fc, Soluble Activin Type IIB Receptor Fusion Protein
ACE-031 works by trapping myostatin, your body's natural brake on muscle growth. By neutralizing this signal, your muscles can grow more freely. Originally developed for muscle-wasting diseases, it's now studied for its ability to increase lean mass, strength, and even bone density without the side effects of steroids.
ACE-031
ACE-031
ACE-031
ACE-031 Evidence Snapshot
How these guides are reviewed
REGULATORY STATUS
Not FDA approved · research use only
DOSING GUIDANCE
Reviewed by our clinical team
LINKED EVIDENCE
1 research sources
CONTENT UPDATED
Aug 28, 2026
Dose and schedule recommendations shown below come from The Peptide App Clinical Team. Research links are provided so readers can inspect the supporting evidence directly. Review the sources.
Quick Answers About ACE-031
What dose does The Peptide App Clinical Team recommend for ACE-031?
Dose: 100-200 mcg, 1-3 times per week.
MORE CONTEXT ›
Schedule: daily. Cycle: 4-8 weeks on, then 4-8 weeks off. This is clinical-team guidance for reference and does not replace individualized instructions from a licensed clinician.
What research supports this ACE-031 guide?
This guide links to 1 curated or current research sources.
MORE CONTEXT ›
Open the research section to inspect the source titles, publication details, study types, and available abstracts directly.
Studied Effects & Mechanisms
Myostatin Blocker
Traps myostatin before it can limit muscle growth
Muscle Builder
Enables uninhibited muscle cell growth and hypertrophy
Bone Support
Improves bone mineral density and metabolism
Fat Metabolism
Supports fat burning through improved metabolic efficiency
Bodybuilders looking for non-hormonal muscle support
Athletes recovering from injury or muscle loss
People with age-related muscle decline
Those interested in bone density improvement
ACE-031 Research
Live research temporarily unavailableThe live research feed did not return papers for this page. The curated references below remain available for crawlable source context.
RESEARCH REFERENCES